RKLB

Rocket Lab USA
D

RKLB

Rocket Lab USA cash on hand 2019–2026

Rocket Lab USA had 4.61B USD in cash and short-term investments on 30 September 2026, up 371.8% on a year before. At the end of fiscal year 2025 it had 1.02B USD.

Last updated 9 Nov 2026 · Next report 25 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 20264.61B+371.77%118.57M4.49B
FY202531 Dec 20251.02B+142.63%253.96M762.62M
FY202431 Dec 2024418.99M+71.17%468.42M-49.43M
FY202331 Dec 2023244.77M-48.12%176.69M68.09M
FY202231 Dec 2022471.79M-31.72%152.78M319.01M
FY202131 Dec 2021690.96M+1,208.83%128.43M562.53M
FY202031 Dec 202052.79M-44.94%27.30M25.49M
FY201931 Dec 201995.88M—26.03M69.85M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Balance sheet

Common questions about Rocket Lab USA's cash

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.